Zanatta Paolo, Forti Alessandro, Bosco Enrico, Salvador Loris, Borsato Maurizio, Baldanzi Fabrizio, Longo Carolina, Sorbara Carlo, Longatti Pierluigi, Valfrè Carlo
Anestesia and Intensive Care Department, Treviso Regional Hospital, Italy.
J Cardiothorac Surg. 2010 Feb 4;5:5. doi: 10.1186/1749-8090-5-5.
Extracorporeal membrane oxygenation (ECMO) supplies systemic blood perfusion and gas exchange in patients with cardiopulmonary failure. The current literature lacks of papers reporting the possible risks of microembolism among the complications of this treatment.In this study we present our preliminary experience on brain blood flow velocity and emboli detection through the transcranial Doppler monitoring during ECMO.
Six patients suffering of heart failure, four after cardiac surgery and two after cardiopulmonary resuscitation were treated with ECMO and submitted to transcranial doppler monitoring to accomplish the neurophysiological evaluation for coma.Four patients had a full extracorporeal flow supply while in the remaining two patients the support was maintained 50% in respect to normal demand.All patients had a bilateral transcranial brain blood flow monitoring for 15 minutes during the first clinical evaluation.
Microembolic signals were detected only in patients with the full extracorporeal blood flow supply due to air embolism.
We established that the microembolic load depends on gas embolism from the central venous lines and on the level of blood flow assistance.The gas microemboli that enter in the blood circulation and in the extracorporeal circuits are not removed by the membrane oxygenator filter.Maximum care is required in drugs and fluid infusion of this kind of patients as a possible source of microemboli. This harmful phenomenon may be overcome adding an air filter device to the intravenous catheters.
体外膜肺氧合(ECMO)为心肺功能衰竭患者提供全身血液灌注和气体交换。目前的文献缺乏关于该治疗并发症中微栓塞可能风险的报道。在本研究中,我们展示了通过ECMO期间经颅多普勒监测对脑血流速度和栓子检测的初步经验。
6例心力衰竭患者,4例心脏手术后患者和2例心肺复苏后患者接受了ECMO治疗,并接受经颅多普勒监测以完成昏迷的神经生理学评估。4例患者接受全体外循环血流供应,而其余2例患者的支持维持在正常需求的50%。所有患者在首次临床评估期间进行双侧经颅脑血流监测15分钟。
仅在因空气栓塞而接受全体外循环血流供应的患者中检测到微栓塞信号。
我们确定微栓塞负荷取决于中心静脉管路的气体栓塞和血流辅助水平。进入血液循环和体外循环的气体微栓子不能被膜式氧合器过滤器清除。对于这类患者,在药物和液体输注时需要格外小心,因为这可能是微栓子的来源。通过在静脉导管上添加空气过滤装置,这种有害现象可能会被克服。